Mentions
Extended reach
Total likes
Video views
AI synopsis
Participants express appreciation for the comprehensive review of mechanisms and clinical trial implications, often mentioning key aspects like insulin resistance and microbiome imbalance, which reflect a focused engagement. The tone is scientific and respectful, highlighting the article's potential to shape ongoing and future research rather than generating controversy or high excitement.
Most discussions agree that the publication offers valuable insights into the mechanisms and potential treatments of metabolic liver disease in diabetes.
Participants show moderate interest, acknowledging the relevance but not expressing high enthusiasm or controversy.
Comments include references to specific mechanisms like cytokine release and gut microbiome, indicating a thoughtful and engaged approach.
The discussions suggest the article could influence future research directions, although the overall tone remains analytical.
#Metabolic liver disease in #diabetes – From mechanisms to clinical trials - a review of Michale Roden @ddz_info and Colleagues in @MolMetab. https://t.co/QaozwJvRAs
Metabolic liver disease in diabetes - from mechanisms to clinical trials. https://t.co/6aaLWOl6EM https://t.co/P08dItT4Mn
This video discusses the diagnosis of metabolic dysfunction-associated fatty liver disease (MASLD) using current guidelines. It covers key assessment methods like Fib4 and elastography and addresses criteria for…
This video covers clinical guidelines for identifying and treating nonalcoholic fatty liver disease, emphasizing diagnosis through imaging and managing risk factors like diabetes and obesity to prevent progression.
#Metabolic liver disease in #diabetes – From mechanisms to clinical trials - a review of Michale Roden @ddz_info and Colleagues in @MolMetab. https://t.co/QaozwJvRAs
Metabolic liver disease in diabetes - from mechanisms to clinical trials. https://t.co/6aaLWOl6EM https://t.co/P08dItT4Mn